TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07898072: Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism

Sponsor: Amneal Pharmaceuticals, LLC · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 190 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$2,074,336

Rescue Site Savings

+$1,367,176

Unlock Full NCT07898072 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07898072 Rescue Dossier →